A case of tacrolimus-induced supraventricular arrhythmia after kidney transplantation
Keywords:
Tacrolimus, Arrhythmias, cardiac, Kidney transplantation, Tachycardia, supraventricular, Atrial premature complexesAbstract
CONTEXT: Tacrolimus is a potent immunosuppressive drug often administered to transplant recipient patients and exhibits a variety of adverse cardiovascular effects. CASE REPORT: We report a case of a 53-year-old Asian female who developed various arrhythmic phenomena including atrial premature complexes and supraventricular tachycardia after administration of tacrolimus. CONCLUSION: Tacrolimus-associated arrhythmia after kidney transplantation may be life-threatening, and so patients undergoing this procedure should be carefully monitored.
Downloads
References
Johnson MC, So S, Marsh JW, Murphy AM. QT prolongation and Torsades de Pointes after administration of FK506. Transplantation. 1992;53(4):929-30.
Hodak SP, Moubarak JB, Rodriguez I, et al. QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report. Transplantation. 1998;66(4):535-7.
Minematsu T, Ohtani H, Sato H, Iga T. Pharmacokinetic/ pharmacodynamic analysis of tacrolimus-induced QT prolongation in guinea pigs. Biol Pharm Bull. 1999;22(12):1341-6.
Nishimura M, Kim K, Uchiyama A, et al. Tacrolimus-induced life- threatening arrhythmia in a pediatric liver-transplant patient. Intensive Care Med. 2002;28(11):1683-4.
Marcassi AP, Yasbek DC, Pestana JO, et al. Ventricular arrhythmia in incident kidney transplant recipients: prevalence and associated
factors. Transpl Int. 2011;24(1):67-72.
